There are so many more options right now for parents to feed their babies. Here's what you need to know about some of the newer goat's milk-based formulas.
The approval of Casgevy, Vertex Pharmaceuticals Inc. and Crispr Therapeutics Inc.’s gene therapy for sickle cell disease, is a transformative moment in medicine. Not only is it the first Crispr-based drug to reach the market it’s a potentially life-altering advance for a patient population that has been for too long ignored and underserved by the medical establishment. Lyfgenia, a second gene therapy f.
Regulators have approved two gene therapies for sickle cell disease that doctors hope can cure the painful, inherited blood disorder that afflicts mostly Black people in the U.S. The Food and Drug Administration said the one-time treatments can be used for patients 12 and older with severe forms of the…